Business
Completion of Director Placing
Completion of Director Placing.
About this update from Judges Scientific Plc
[{"type":"text","content":"\n \nRNS Number : 1281T Judges Scientific PLC 10 October 2017 \n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL (\"RESTRICTED JURISDICTIONS\").\nThis announcement contains inside information for the purposes of the Market Abuse Regulation (EU) No 596/2014 (\"MAR\"). Market soundings, as defined in MAR, were taken in respect of the Placing, with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.\nPLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT \n \n \n10 October 2017\n \nJudges Scientific plc\n(\"Judges Scientific\", \"the Company\", or \"the Group\")\n Completion of Director Placing\n Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces that, further to the announcement of 9 October 2017 regarding a proposed placing of ordinary shares by David Cicurel, it has been notified that he has placed a total of 157,727 ordinary shares in the Company (\"Placing Shares\") at a price of 1,900 pence per share (the \"Placing\") with a number of new and certain existing institutional shareholders. \nShore Capital Stockbrokers Limited acted as Sole Bookrunner to the Placing, which was oversubscribed.\nThe revised Shareholding for David Cicurel is set out below:\n\n\n\n\n\n\n\nShareholding prior to the Placing\n\n\nOrdinary Shares sold\n\n\nResultant shareholding\n\n\n\n\nNumber\n\n\n%\n\n\nNumber\n\n\n%\n\n\nNumber\n\n\n%\n\n\n\n\nDavid Cicurel*\n\n\n916,954\n\n\n14.98%\n\n\n157,727\n\n\n2.58%\n\n\n759,227\n\n\n12.40%\n\n\n\n\n \n* Includes 50,000 Ordinary Shares held by his wife.\nFor further enquiries, please contact: \n\n\n\n\nJudges Scientific plc\nDavid Cicurel, CEO\nBrad Ormsby, FD\n \n\n\nTel: 020 3829 6970\n \n\n\n \n\n\n\n\nShor...